Zylpha Announces 2022 ‘Legal Innovation Award’ Winners
Leading UK Legal systems developer Zylpha (www.zylpha.com) has announced the winners of its annual ‘Legal…
Leading UK Legal systems developer Zylpha (www.zylpha.com) has announced the winners of its annual ‘Legal…
Alongside launching North America operations, Appear expands its NEO Series offering with the release of…
The first myWorld Keynote of the year took place on the 5th of March in…
Evrysdi® (risdiplam) data further confirm long-term efficacy and safety data in a broad range of…
VLA1553-301 six-month follow-up completed – all endpoints met Seroprotection (protective CHIKV neutralizing antibody levels) in…
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…
BANGALORE, India–(BUSINESS WIRE)–o9 Solutions, a leading enterprise AI-powered platform provider for integrated business planning and…
Company Invests in Women to Become the Premier Cybersecurity Workplace SAN JOSE, Calif.–(BUSINESS WIRE)–Trellix, the…
MIAMI–(BUSINESS WIRE)–$CYXT #colocation—Cyxtera (NASDAQ: CYXT), a global leader in data center colocation and interconnection services,…
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the…
Conference Call to be Held on March 9, 2022 at 8:30am ET to Discuss Transaction…
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
BOSTON, March 07, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology…
Initiation of the NATiV3 Phase III clinical trial with lanifibranor in NASH Receipt of a…
Completed dosing in Phase 2a clinical trial of ETX-810 in subjects with diabetic peripheral neuropathic…
FDA approval supports corporate goal of plasma supply self-sufficiency and ongoing revenue growth Company positioned to…
SANTA MONICA, Calif., March 07, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…